Predictive oncology enters biomarker discovery market after successful retrospective ovarian cancer study yields compelling results

Expands ai/ml driven offering to include novel oncology biomarker discovery to predict patient outcomes and drug response in oncology

POAI Ratings Summary

POAI Quant Ranking